Figure 2From: Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinomaBreast carcinoma specific overall survival (B1) and specific disease-free survival (B2) of 308 breast carcinoma patients according to the presence or absence of LEPR 223Rallele (p denotes the log-rank test value).Back to article page